Dextromethorphan Hydrobromide Hydrate [6700-34-1]
D1792
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameDextromethorphan Hydrobromide Hydrate [6700-34-1]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatSoluble in water (15 mg/mL).
- Scientific Descriptionσ1/2and mu/kappa/delta-OR agonist, alfa3bèta4/alfa4bèta2/alfa7 nAChR, SERT, NET, NMDA antagonist.; ( )-3-Methoxy-N-methylmorphinon, delta-Methorphan
- Storage InstructionAmbient
- UNSPSC12352200
References
- Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75-82. PMID: 24648790. Wu K, Lin TH, Liou HC, et al. Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-kappaB activation. Osteoporos Int. 2013 Aug;24(8):2201-14. PMID: 23400250. Damaj MI, Flood P, Ho KK, et al. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J Pharmacol Exp Ther. 2005 Feb;312(2):780-5. PMID: 15356218. Zhang W, Wang T, Qin L, et al. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 2004 Mar;18(3):589-91. PMID: 14734632. Chou YC, Liao JF, Chang WY, et al. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res. 1999 Mar 13;821(2):516-9. PMID: 10064839.